Qiagen, LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersGermantown, MD
SAM.gov UEIW2GLKC92ZH73
QIAGEN makes sample extraction platforms and diagnostic testing solutions. The company produces instruments for automated clinical sample extraction, including the QIAsymphony Connect platform, along with diagnostic products for infectious disease, oncology, and other clinical applications such as QuantiFERON-TB Gold Plus, QIAstat-Dx Syndromic Testing, and therascreen Solid Tumor. The company serves discovery and translational research, diagnostics and clinical research, human identification and forensics, and next-generation sequencing markets.
Summarized from the company’s own website
What they make
Applicator, Absorbent Tipped, SterileDna-Reagents, ChlamydiaDna-Reagents, NeisseriaGeneral Purpose ReagentImmunoassay For Detection Of Amniotic Fluid Protein(S).Kit, Dna Detection, Human PapillomavirusNext-generation sequencingPlacental Alpha Microglobulin-1 ImmunoassayReagents, Specific, AnalyteSingle (Specified) Analyte Controls (Assayed And Unassayed)Spatula, Cervical, CytologicalStation, Pipetting And Diluting, For Clinical UseTest, Immunity, Cell Mediated, Mycobacterium Tuberculosis
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Qiagen, LLC | Germantown | MD | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.